Imstar

Validation of MN assay scoring

Wed, 15 Oct 2008 17:10:38 +0100

IMSTAR is co-author of a paper published in Mutagenesis by the team of Micheline Kirsch-Volders at the Vrije Universiteit Brussels in Belgium. This work validates the automated scoring for Micronucleus assay using IMSTAR Pathfinder™ technology on human lymphocytes stained in Giemsa under the CBMN method. While performed in the frame of NewGeneris European Program in which IMSTAR is a partner, this paper demonstrates IMSTAR's cutting edge performances in the field of automated scoring for genetic toxicology. IMSTAR proposes integrated solutions for automated scoring of micronucleus assay, comet assay, chromosome aberrations scoring and mitotic index measurement on a broad variety of cells and stainings. For more information, click here and contact us today. Thanks to Pathfinder™ modular structure, those tests may be multiplexed on the same platform with general cytotoxicity assays.

EEMS 2008

Mon, 22 Sep 2008 17:00:23 +0100

IMSTAR will present two posters at the EEMS conference to be held September 21-25 in Cavtat (Croatia): "Fully automated micronuclei detection and comet assay scoring using Pathinder high-content imaging technology" and "Method comparison for automated high-throughput high-content screening of the comet assay" in collaboration with Andrew Collins's lab (University of Oslo), IMSTAR's partner within COMICS European Project for empowering the comet assay throughput and performances. IMSTAR today offers cutting edge integrated soutions for automated scoring of genetic toxicology assays, including comet and micronucleus assay. At the EEMS conference, you will have the opportunity to meet an IMSTAR's representative. Call us today if you need a specific appointment.

Comet assay on plant cells:

Mon, 21 Jul 2008 09:56:03 +0100

IMSTAR is proud to announce the installation of a Pathfinder™ Cellscan COMET platform at the Institute of Experimental Botany, Academy of Sciences of the Czech Republic, Praha in the DNA repair lab (Dr. Karel J. Angelis). "We already noticed IMSTAR's expertise in quantitative imaging for comet assay in the COMICS European project we are involved in. We appreciate IMSTAR's customer-oriented attitude to adapt to such complex assays as comets on plant cells", says Karel Angelis. This tool will increase the scoring capacity and the precision for assays where reproductibility and ability to detect comets with various shapes is a key issue.

COMICS course in Bratislava:

Tue, 08 Jul 2008 12:24:10 +0100

IMSTAR will be part of the next COMICS course to be held September 17-19 in Bratislava (Slovakia). This course, organised by TATAA Biocenter will give a comprehensive overview of the most advanced techniques in the field of Comet assay and teach them to researchers (for inscriptions, please contact TATAA Biocenter). This knowledge and know-how represent dissemination of the advancements of the COMICS European program (6th PCRD, leader: Andrew Collins) in which IMSTAR is partner for revolutionizing high-throughput high-content scoring techniques using different formats (slides, Gelbonds™, cell-on-chips). For more information, contact IMSTAR today.

IMSTAR becomes a key player in China

Tue, 27 May 2008 12:15:41 +0100

In partnership with Naturegene Corp., its long-term exclusive distributor in China, IMSTAR is proud to announce its successful entry on the Chinese market of automated cytogenetics for cancer diagnostic. The french company has been choosen for providing diagnostic labs with 380 platform from the Pathfinder technology. "Versatility and automation are key features on the fast-growing Chinese market, therefore is IMSTAR's patented technology the most appropriate partner for Chinese labs to meet international cutting-edge standarts" says Françoise Soussaline, IMSTAR's CEO. Together with Naturegene Corp., IMSTAR is in strong position to extend its market shares on the Chinese diagnostic market and also to genetic toxicology for which IMSTAR provides solutions amongst the most advanced wordlwide.

RNAi World Congress in Boston

Mon, 28 Apr 2008 15:45:12 +0100

Xavier Gidrol, from Service de Génomique fonctionelle of the French atomic energy commission (CEA), will give a talk at the RNAi World Congress to be held 04/30/2008 to 05/02/08 in Boston on the "Genome-Wide Screen for Kinases Involved in Phosphorylation of Histone H2AX, using siRNA Microarrays". This work has been performed in collaboration with IMSTAR, the leading company for high-content high-throughput phenotyping on cell-on-chips.

IMSTAR & point mutation detection on DNA microarray

Wed, 06 Feb 2008 11:30:03 +0100

IMSTAR is co-author of an article published in the current issue of BioTechnique. This work, entitled "A highly specific microarray method for point mutation detection" has been performed in collaboration with the team of Franck Sturtz at the Department of Biochemistry & Molecular Genetics of the university of Limoges (France), the Department of Neurology at the University Hospital in Limoges, the ESPCI/INSERM in Paris and Serial Genetics company in Evry. This article emphasizes IMSTAR OSA technology's unique features enabling real-time hybridization curves measurements and unique characterization of DNA microarrays using Pathfinder™ technology. Learn more about this work clicking here.

Article in BioTechniques

Tue, 15 Jan 2008 14:00:05 +0100

IMSTAR team has published an article in BioTechnique (January 2008, col. 44, n°1, pp109-17) in collaboration with the team of Marie-Claude Potier & Jean Rossier from the Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI). This work about on-chip hybridization kinetics for optimisation of gene expression experiments has been achieved thanks IMSTAR's patented technology enabling full control of chip temperature at a speed comparable to the one of PCR thermocyclers. It opens new avenues for on-chip experiments quantification and quality control.

IMSTAR in Newzy

Mon, 17 Dec 2007 10:11:08 +0100

The french business magazine Newzy published in its November issue an article about IMSTAR's latest developments concerning tailored tools in cancer diagnostic and treatment and human genomic risk assessment. IMSTAR's innovative solution for multiplex phenotyping by high throughput functional cellular analysis is examplified by its pilote position in BIOTYPE research program co-funded by the French Ministry of Industry and the Paris region. In addition, the company is a key actor for human genomic risk assessment thanks to its leadership in automated scoring of genetic toxicology assays.

Comet Assay Course

Thu, 27 Sep 2007 09:49:15 +0100

Françoise Soussaline, IMSTAR's CEO & CSO, will give a course on automated screening systems for comet assay at COMICS course held by TATAA in Oslo (October 1st-3rd 2007). IMSTAR is part of COMICS European Program for empowering comet assay. This program is led by prestigious expert and IMSTAR's customer Andrew Collins.

EEMS 2007 Basel

Wed, 05 Sep 2007 16:56:30 +0100

IMSTAR will present two posters at the EEMS 2007 congress in Basel (9th to 13th September): "Fully Automated Screening of Comet Assay using FISH on DNA Repeated Sequences" in collaboration with Andrew Collins team (UiO, Oslo, Norway) and "Fully Automated Micronuclei & Comet Assay Scoring Using Pathfinder High-Content Imaging Technology". If you wish to meet our team on this occasion, please contact us today.

Gordon Research Conference 2007

Wed, 25 Jul 2007 10:03:44 +0100

Xavier Gidrol, from the Service de Génomique Fonctionnelle of the CEA (French Atomic Energy Commission) will present a poster in collaboration with IMSTAR at the Gordon Research Conference 2007 "EPITHELIAL DIFFERENTIATION & KERATINIZATION" held in Rhode Island from July the 29th to August the 3rd 2007. This poster presents the latest achievements of Pathfinder technology for high-content screening using cell on chips examplified by the genome-wide screen for kinases involved in phosphorylation of histoneH2AX in response to irradiation in human keratinocytes.

IMSTAR leader for Cellular Analysis:

Fri, 06 Jul 2007 15:49:29 +0100

Paris Développement, the Paris region agency for business development has published an article about IMSTAR's latest improvement in Cellular Analysis. This article may be read clicking here. IMSTAR's proposes key solutions for multiplex cellular analysis and genetic toxicology, as well as for cytopathology.

VII Comet Assay Workshop - Coleraine:

Mon, 18 Jun 2007 18:59:27 +0100

IMSTAR is the partner of the VIIth Comet Assay Workshop to be held in Coleraine (Northern Ireland) on June the 24th-27th. On this occasion, IMSTAR and its partners will present several posters and a talk. For any information on this event, please visit the workshop's website clicking here or contact us.

IMSTAR in Biotech Info

Thu, 10 May 2007 15:40:17 +0100

Biotech Info, the french information letter for biotech industries, has portrayed IMSTAR. In the Letter n°352, IMSTAR is described as an innovative company deeply involved in international experts consortia. For more information, visit Biotech Info website: www.biotechinfo.fr.